Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Continued evasion of neutralizing antibody response by Omicron XBB.1.16
Julia N. Faraone, Panke Qu, Yi-Min Zheng, et al.
Cell Reports (2023) Vol. 42, Iss. 10, pp. 113193-113193
Open Access | Times Cited: 19

Showing 19 citing articles:

Sotrovimab: A Review of Its Efficacy against SARS-CoV-2 Variants
Daniele Focosi, Arturo Casadevall, Massimo Franchini, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 217-217
Open Access | Times Cited: 19
Spatiotemporal dynamics and epidemiological impact of SARS-CoV-2 XBB lineage dissemination in Brazil in 2023
Ighor Arantes, Marcelo Ferreira da Costa Gomes, Kimihito Ito, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 3
Open Access | Times Cited: 5
Immunogenicity of second booster-dose COVID-19 mRNA vaccine among older adults in Taiwan
Hao-Yuan Lee, Chih-Hsien Chuang, Chung‐Guei Huang, et al.
Biomedical Journal (2025), pp. 100834-100834
Open Access
SARS-CoV-2 Omicron: Viral Evolution, Immune Evasion, and Alternative Durable Therapeutic Strategies
Hailong Guo, Sha Ha, Jason Botten, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 697-697
Open Access | Times Cited: 4
Immune Evasion of SARS-CoV-2 Omicron Subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a Cohort of Older Adults after ChAdOx1-S Vaccination and BA.4/5 Bivalent Booster
Rafael Rahal Guaragna Machado, Erika Donizette Candido, Andressa Simões Aguiar, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 144-144
Open Access | Times Cited: 3
Temperature-dependent Spike-ACE2 interaction of Omicron subvariants is associated with viral transmission
Mehdi Benlarbi, Shilei Ding, Étienne Bélanger, et al.
mBio (2024) Vol. 15, Iss. 8
Open Access | Times Cited: 3
Epidemiological characteristics and antibody kinetics of elderly population with booster vaccination following both Omicron BA.5 and XBB waves in China
Xin‐Jing Zhao, Xiaolin Liu, Yu‐Min Liang, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 5
Open Access | Times Cited: 2
Self-Assembling Sulfated Lactobacillus Exopolysaccharide Nanoparticles as Adjuvants for SARS-CoV-2 Subunit Vaccine Elicit Potent Humoral and Cellular Immune Responses
Shuo Zhang, Wentao Fan, Chenchen Ding, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 15, pp. 18591-18607
Closed Access | Times Cited: 1
Specific humoral immune response and XBB variants re-infection risk of hemodialysis patients after Omicron BA.5 infection in China
Weikang Mai, Jinwei Shen, Feifei Ma, et al.
Vaccine (2024) Vol. 42, Iss. 21, pp. 126108-126108
Closed Access | Times Cited: 1
Worldwide SARS-CoV-2 Omicron variant infection: Emerging sub-variants and future vaccination perspectives
Yu-An Kung, Chih-Hsien Chuang, Yi-Ching Chen, et al.
Journal of the Formosan Medical Association (2024)
Open Access | Times Cited: 1
Peptidomimetic Analogues Act as Effective Inhibitors against SARS-CoV-2 by Blocking the Function of Cathepsin L
Weilong Deng, Xiao Hu, Xiaoman Tian, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 19, pp. 17124-17143
Closed Access | Times Cited: 1
Safety, Tolerability, and Immunogenicity of Booster Dose with MVC-COV1901 or MVC-COV1901-Beta SARS-CoV-2 Vaccine in Adults: A Phase I, Prospective, Randomized, Open-Labeled Study
Chia-En Lien, Ming‐Che Liu, Ning‐Chi Wang, et al.
Vaccines (2023) Vol. 11, Iss. 12, pp. 1798-1798
Open Access | Times Cited: 2
Differentiating Cell Entry Potentials of SARS-CoV-2 Omicron Subvariants on Human Lung Epithelium Cells
Revansiddha Katte, Yuanyun Ao, Xu Wang, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 391-391
Open Access
Immunogenicity of Second Booster-Dose COVID-19 mRNA Vaccine Among Older Adults in Taiwan
Hao-Yuan Lee, Chih-Hsien Chuang, Chung‐Guei Huang, et al.
(2024)
Closed Access
Longitudinal Analysis of Neutralizing Antibodies Against SARS-CoV-1 and Different SARS-CoV-2 Strains in Breakthrough and Unvaccinated Covid-19 Patients in Thailand
Prapassorn Poolchanuan, Vichapon Tiacharoen, Adul Dulsuk, et al.
(2024)
Closed Access
Dynamic changes of neutralizing antibody and memory T cell responses six months post Omicron XBB reinfection
Xin‐Jing Zhao, Xin‐Lou Li, Sheng Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Fitness of SARS-CoV-2 Omicron subvariants in respiratory and gastrointestinal cell lines as determined by RT-ddPCR and whole genome sequencing
Mathilde Hénaut, Julie Carbonneau, Inès Levade, et al.
The Journal of Infectious Diseases (2024)
Open Access
Emergence of Omicron FN.1 a descendent of BQ.1.1 in Botswana
Wonderful T. Choga, Emanuele Gustani-Buss, Houriiyah Tegally, et al.
Virus Evolution (2024) Vol. 10, Iss. 1
Open Access
Spatiotemporal dynamics and epidemiological impact of SARS-CoV-2 XBB lineages dissemination in Brazil in 2023
Ighor Arantes, Marcelo Ferreira da Costa Gomes, Kimihito Ito, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top